SAMJIN PHARMACEUTICAL CO.,LTD Logo

SAMJIN PHARMACEUTICAL CO.,LTD

Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.

005500 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 마포구 와우산로 121 삼진제약사옥, 마포구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Samjin Pharmaceutical Co., Ltd. is a Korean pharmaceutical company dedicated to the research, development, and manufacturing of treatments to improve human health. The company focuses on creating innovative therapies for diseases with high unmet medical needs, including cardiovascular, respiratory, and gastrointestinal disorders, with an ambition to become a global leader in the field. Through significant investment in R&D, Samjin has developed a diverse portfolio of both prescription and over-the-counter medications. Key products include the antiplatelet drug Plariss, the analgesic Geborin, and the hypercholesterolemia treatment Newstatin R. The company emphasizes securing technological competitiveness and building a robust pipeline of novel drugs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-08-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-12 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 27.9 KB
2025-05-12 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 18.4 KB
2025-03-21 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.7 KB
2025-03-21 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.2 KB
2025-03-21 00:00
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
Korean 5.7 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 11.3 KB
2025-03-13 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.4 MB

Automate Your Workflow. Get a real-time feed of all SAMJIN PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SAMJIN PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.